Cargando…

Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control

OBJECTIVE: To investigate a possible beneficial effect of strict glycaemic control on all-cause mortality in patients with peripheral arterial disease and type 2 diabetes mellitus. METHODS: A total of 367 mainly older peripheral arterial disease patients [age: 69 (62–78) years, 34% women, Fontaine s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Höbaus, Clemens, Herz, Carsten Thilo, Wrba, Thomas, Koppensteiner, Renate, Schernthaner, Gerit-Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510380/ https://www.ncbi.nlm.nih.gov/pubmed/32308023 http://dx.doi.org/10.1177/1479164120914845

Ejemplares similares

Vascular peroxidase 1 is independently associated with worse kidney function in patients with peripheral artery disease
por: Costas, Lavinia, et al.
Publicado: (2020)

Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes
por: Zierfuss, Bernhard, et al.
Publicado: (2019)

Soluble urokinase-type plasminogen activator receptor predicts peripheral artery disease severity and outcomes
por: Höbaus, Clemens, et al.
Publicado: (2021)

Angiogenin—A Proposed Biomarker for Cardiovascular Disease—Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease
por: Höbaus, Clemens, et al.
Publicado: (2021)

NT-proBNP as a surrogate for unknown heart failure and its predictive power for peripheral artery disease outcome and phenotype
por: Zierfuss, Bernhard, et al.
Publicado: (2023)

Endothelial Progenitor Cells Are Related to Glycemic Control in Children With Type 1 Diabetes Over Time
por: Hörtenhuber, Thomas, et al.
Publicado: (2013)

YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease
por: Schernthaner, Gerit-Holger, et al.
Publicado: (2016)

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease
por: Lorant, David Peter, et al.
Publicado: (2011)

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
por: Schernthaner, Guntram, et al.
Publicado: (2013)

Decrease of dipeptidyl peptidase 4 activity is associated with weight loss after bariatric surgery
por: Herz, Carsten T., et al.
Publicado: (2021)

The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system
por: Schernthaner, Guntram, et al.
Publicado: (2014)

Individualisierung der antihypertensiven Therapie bei Patient:innen mit Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2023)
por: Saely, Christoph H., et al.
Publicado: (2023)

Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010
por: Schernthaner, Guntram, et al.
Publicado: (2011)

To the editor regarding article “Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study”
por: Mayer, Florian J., et al.
Publicado: (2018)

The importance of socio-economic determinants of health in the care of patients with peripheral artery disease: A narrative review from VAS
por: Kolossváry, Endre, et al.
Publicado: (2023)

Glucose-lowering therapy in type 2 diabetes: New hope after the EMPA-REG outcome trial
por: Schernthaner, G., et al.
Publicado: (2016)

Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies
por: Schernthaner, Guntram, et al.
Publicado: (2018)

OLDER AGE IS (STILL) ASSOCIATED WITH MENTAL HEALTH BENEFITS IN JUNE–JULY 2021 OF THE COVID-19 PANDEMIC
por: Chappell, Amanda, et al.
Publicado: (2022)

Involvement of APOE in Incidence of Revascularization in Patients Affected by Peripheral Arterial Disease: A Prospective Study from Southern Italy
por: Di Stolfo, Giuseppe, et al.
Publicado: (2023)

Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo
por: Bauer, Michael, et al.
Publicado: (2012)

Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?
por: Schernthaner, Guntram
Publicado: (2021)

Renal Function but Not Asymmetric Dimethylarginine Is Independently Associated with Retinopathy in Type 2 Diabetes
por: Krzyzanowska, Katarzyna, et al.
Publicado: (2011)

Benefits of screening cancer patients for distress still not demonstrated
por: Coyne, J C
Publicado: (2013)

Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy
por: Gremmel, Thomas, et al.
Publicado: (2015)

Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease—Pathophysiology and Translational Therapeutic Approaches
por: Poledniczek, Michael, et al.
Publicado: (2023)

Reply: benefits of screening cancer patients for distress still not demonstrated
por: Carlson, L E, et al.
Publicado: (2013)

The Benefits of Breastfeeding Still Outweigh the Risks of COVID-19 Transmission
por: Lou, Fuxing, et al.
Publicado: (2021)

Influenza vaccination in the elderly: why are the overall benefits still hotly debated?
por: TRUCCHI, C., et al.
Publicado: (2015)

α-Hydroxybutyrate dehydrogenase is associated with atherothrombotic events following infrainguinal angioplasty and stenting
por: Lee, Silvia, et al.
Publicado: (2019)

Children and Older Adults Exhibit Distinct Sub-Optimal Cost-Benefit Functions when Preparing to Move Their Eyes and Hands
por: Gonzalez, Claudia C., et al.
Publicado: (2015)

Benefit of prokinetics during enteral nutrition: still searching for a piece of evidence
por: Dive, Alain
Publicado: (2016)

Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older
por: Huang, Shan, et al.
Publicado: (2017)

Counterpoint: Intensive Glucose Control and Mortality in ACCORD—Still Looking for Clues
por: Riddle, Matthew C.
Publicado: (2010)

Is an Oral Glucose Tolerance Test Still Valid for Diagnosing Diabetes Mellitus?
por: Kim, Dong-Lim, et al.
Publicado: (2016)

Use of Continuous Glucose Monitoring in Older Adults: A Review of Benefits, Challenges and Future Directions
por: Prasad-Reddy, Lalita, et al.
Publicado: (2022)

SAT-431 Parameters of Glucose Metabolism Independently Predict Post Glucose Load Growth Hormone Concentrations in Patients with Acromegaly
por: Micko, Alexander, et al.
Publicado: (2019)

Quantitative multiplex immunohistochemistry with colorimetric staining (QUIVER) may still benefit from MILAN
por: Bolognesi, Maddalena M., et al.
Publicado: (2023)

Frailty still matters to health and survival in centenarians: the case of China
por: Gu, Danan, et al.
Publicado: (2015)

The Mental Health Benefits of Physical Activity in Older Adults Survive the COVID-19 Pandemic
por: Callow, Daniel D., et al.
Publicado: (2020)

The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma
por: Cao, Zhiyou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p9i4jkedmcj7hqftocrng9adt5